Anavex Life Sciences Corporation (AVXL)

Anavex Life Sciences Corporation Azioni (AVXL) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	2.54% 2.008	1.9582	1.8279	1.4652	1.2676
Operating Expenses	10.74% 11.29	12.65	13.53	14.19	15.38
Benefits Costs and Expenses	13.34% 10.54	12.17	13.07	14.52	14.26
Costs And Expenses	13.34% 10.54	12.17	13.07	14.52	14.26
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	10.74% -11.29	-12.65	-13.53	-14.19	-15.38
Net Interest Income/Expense	2.54% 2.008	1.9582	1.8279	1.4652	1.2676
Nonoperating Income/Loss	12.85% 2.756	2.4422	2.2917	1.1319	2.3922
Income/Loss From Continuing Operations Before Tax	16.39% -8.537	-10.21	-11.24	-13.06	-12.99
Income Tax Expense/Benefit, Current	232.91% 0.085	-0.064	0.041	0.05	-0.02
Income Tax Expense/Benefit	249.24% 0.085	-0.057	0.041	0.05	-0.02
Income/Loss From Continuing Operations After Tax	15.08% -8.622	-10.15	-11.28	-13.11	-12.97
Net Income/Loss	15.02% -8.622	-10.15	-11.28	-13.11	-12.97
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	82.08	-	-	-	-
Diluted Average Shares	82.08	-	-	-	-
Basic Earnings Per Share	-0.11	-	-	-	-
Diluted Earnings Per Share	-0.11	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-